Compare CRL & WMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRL | WMS |
|---|---|---|
| Founded | 1947 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Containers/Packaging |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.8B | 10.3B |
| IPO Year | 1999 | 2014 |
| Metric | CRL | WMS |
|---|---|---|
| Price | $260.72 | $149.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 8 |
| Target Price | ★ $198.27 | $180.63 |
| AVG Volume (30 Days) | ★ 786.4K | 575.4K |
| Earning Date | 05-07-2026 | 05-21-2026 |
| Dividend Yield | N/A | ★ 0.49% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 5.44 |
| Revenue | $1,857,601,000.00 | ★ $3,050,376,000.00 |
| Revenue This Year | N/A | $5.23 |
| Revenue Next Year | $3.04 | $12.79 |
| P/E Ratio | ★ N/A | $27.53 |
| Revenue Growth | ★ 10.48 | 5.03 |
| 52 Week Low | $144.26 | $125.10 |
| 52 Week High | $242.73 | $179.32 |
| Indicator | CRL | WMS |
|---|---|---|
| Relative Strength Index (RSI) | 72.25 | 57.72 |
| Support Level | $153.47 | $149.92 |
| Resistance Level | N/A | $155.15 |
| Average True Range (ATR) | 8.53 | 4.52 |
| MACD | 0.51 | 0.50 |
| Stochastic Oscillator | 77.93 | 85.02 |
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Advanced Drainage Systems Inc designs, manufactures and markets water management solutions in the stormwater and onsite wastewater industries, providing superior drainage solutions for use in the construction and agriculture markets. The company's products are used across a broad range of end markets and applications, including non-residential, residential, infrastructure and agriculture applications. It has two reportable segments: Stormwater and Wastewater. It derives the majority of revenue from the Stormwater segment, which manufactures and markets thermoplastic corrugated pipe and complementary products, including single wall pipe, N-12 HDPE pipe, polypropylene pipe, StormTech, Nyloplast, Inserta Tee, water quality filters and structures, and NDS channel drains, and access boxes.